Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metacognitive and Insight Therapy (MERIT) for Persons With Schizophrenia: Assessment of Session by Session Progress and Outcome.

NCT03427580 is registered in ClinicalTrials.gov with Bar-Ilan University, Israel as lead sponsor.

NCT NCT03427580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03427580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metacognitive and Insight Therapy (MERIT) for Persons With Schizophrenia: Assessment of Session by Session Progress and Outcome.
Lead sponsor
Bar-Ilan University, Israel
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2018
Completion date
August 1, 2021
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diagnosis of schizophrenia spectrum disorders